Literature DB >> 6084761

Effects of verapamil on [3H]norepinephrine release.

T T Zsotér, C Wolchinsky, L Endrenyi.   

Abstract

If calcium entry blocking drugs affect norepinephrine release, this may alter their cardiovascular action by modifying the activity of baroreceptor reflexes. We investigated the effect of verapamil on 3H-release in [3H]norepinephrine-incubated rat arteries and guinea pig vas deferens. Superfusion of tail artery with verapamil (10(-6) - 10(-4) M) increased the 3H-overflow induced by transmural stimulation (1 Hz, 2 ms, 10 V) both in Wistar Kyoto and in spontaneously hypertensive rats. The effect was present also in vessels pretreated with cocaine to inhibit neuronal uptake or with yohimbine to block alpha 2-adrenoceptors. The greatest increase in 3H-overflow--around 400% in the various groups--was observed after perfusion with 10(-4) M verapamil. In other experiments, we found that verapamil also enhanced 3H-overflow from vessels not stimulated transmurally; this effect again was dose-related (p less than 0.001). In the vas deferens of the guinea pig, 10(-5) M verapamil increased spontaneous and electrical stimulation-induced 3H-release (p less than 0.001), whereas superfusion of the tissue with 10(-9) and 10(-7) M verapamil was ineffective. The results indicate that verapamil can act on sympathetic nerves to release norepinephrine.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6084761

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  8 in total

1.  Influence of glyceryl trinitrate and nifedipine on coronary sinus blood flow and global myocardial metabolism during coronary artery operation.

Authors:  H B van Wezel; J G Bovill; J J Koolen; M R Patrick; J W Fiolet; J G van der Stroom
Journal:  Br Heart J       Date:  1986-09

2.  Interactions of calcium antagonists and the calcium channel agonist Bay K 8644 on neurotransmission of the mouse isolated vas deferens.

Authors:  G A Rae; J B Calixto
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

3.  Differential effects of Ca antagonists on the noradrenaline release and contraction evoked by nerve stimulation in the presence of 4-aminopyridine.

Authors:  H Kato; Y Takata
Journal:  Br J Pharmacol       Date:  1987-01       Impact factor: 8.739

4.  Calcium channel inhibitors suppress the morphine-withdrawal syndrome in rats.

Authors:  F Bongianni; V Carla; F Moroni; D E Pellegrini-Giampietro
Journal:  Br J Pharmacol       Date:  1986-07       Impact factor: 8.739

5.  Acute haemodynamic and neurohumoral effects of intravenous nisoldipine in patients with severe congestive heart failure.

Authors:  H H Erlemeier; W Kupper; W Bleifeld
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

6.  Inhibition of noradrenaline release by omega-conotoxin GVIA in the rat tail artery.

Authors:  B Clasbrummel; H Osswald; P Illes
Journal:  Br J Pharmacol       Date:  1989-01       Impact factor: 8.739

7.  Differential effect of omega-conotoxin on release of the adrenergic transmitter and the vasoconstrictor response to noradrenaline in the rat isolated kidney.

Authors:  M M el-Din; K U Malik
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

8.  The effect of diltiazem on noradrenaline release.

Authors:  C Wolchinsky; T T Zsotér
Journal:  Br J Pharmacol       Date:  1985-06       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.